PROCTER & GAMBLE HEALTH | BIOFIL CHEMICALS | PROCTER & GAMBLE HEALTH/ BIOFIL CHEMICALS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 38.8 | 181.7 | 21.4% | View Chart |
P/BV | x | 16.0 | 5.3 | 299.4% | View Chart |
Dividend Yield | % | 5.1 | 0.0 | - |
PROCTER & GAMBLE HEALTH BIOFIL CHEMICALS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-24 |
BIOFIL CHEMICALS Mar-24 |
PROCTER & GAMBLE HEALTH/ BIOFIL CHEMICALS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,640 | 79 | 7,157.4% | |
Low | Rs | 4,640 | 41 | 11,317.8% | |
Sales per share (Unadj.) | Rs | 693.5 | 24.6 | 2,818.5% | |
Earnings per share (Unadj.) | Rs | 121.1 | 0.4 | 27,783.4% | |
Cash flow per share (Unadj.) | Rs | 137.6 | 0.7 | 20,183.9% | |
Dividends per share (Unadj.) | Rs | 260.00 | 0 | - | |
Avg Dividend yield | % | 5.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 319.1 | 11.2 | 2,852.2% | |
Shares outstanding (eoy) | m | 16.60 | 16.27 | 102.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 7.4 | 2.4 | 304.4% | |
Avg P/E ratio | x | 42.5 | 137.4 | 30.9% | |
P/CF ratio (eoy) | x | 37.4 | 87.9 | 42.5% | |
Price / Book Value ratio | x | 16.1 | 5.4 | 300.8% | |
Dividend payout | % | 214.7 | 0 | - | |
Avg Mkt Cap | Rs m | 85,323 | 975 | 8,752.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,152 | 5 | 43,379.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 11,513 | 400 | 2,875.6% | |
Other income | Rs m | 156 | 5 | 3,189.8% | |
Total revenues | Rs m | 11,669 | 405 | 2,879.4% | |
Gross profit | Rs m | 2,858 | 8 | 34,982.9% | |
Depreciation | Rs m | 274 | 4 | 6,867.2% | |
Interest | Rs m | 7 | 0 | 1,714.3% | |
Profit before tax | Rs m | 2,733 | 9 | 31,597.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 723 | 2 | 46,371.8% | |
Profit after tax | Rs m | 2,010 | 7 | 28,347.0% | |
Gross profit margin | % | 24.8 | 2.0 | 1,217.3% | |
Effective tax rate | % | 26.5 | 18.0 | 146.7% | |
Net profit margin | % | 17.5 | 1.8 | 985.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,306 | 384 | 2,423.0% | |
Current liabilities | Rs m | 6,253 | 285 | 2,192.1% | |
Net working cap to sales | % | 26.5 | 24.7 | 107.4% | |
Current ratio | x | 1.5 | 1.3 | 110.5% | |
Inventory Days | Days | 298 | 0 | 64,157.0% | |
Debtors Days | Days | 271 | 3,011 | 9.0% | |
Net fixed assets | Rs m | 10,735 | 87 | 12,374.4% | |
Share capital | Rs m | 166 | 163 | 102.0% | |
"Free" reserves | Rs m | 5,131 | 19 | 26,599.8% | |
Net worth | Rs m | 5,297 | 182 | 2,910.0% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,041 | 471 | 4,256.5% | |
Interest coverage | x | 380.6 | 21.6 | 1,762.5% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.9 | 67.6% | |
Return on assets | % | 10.1 | 1.6 | 631.2% | |
Return on equity | % | 37.9 | 3.9 | 973.8% | |
Return on capital | % | 51.7 | 5.0 | 1,038.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 69.6 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 8,013 | NA | - | |
Fx inflow | Rs m | 5,421 | 0 | - | |
Fx outflow | Rs m | 8,013 | 0 | - | |
Net fx | Rs m | -2,592 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,283 | 24 | 9,535.9% | |
From Investments | Rs m | -69 | NA | 29,869.6% | |
From Financial Activity | Rs m | -4,181 | -1 | 334,488.0% | |
Net Cashflow | Rs m | -1,967 | 22 | -8,757.3% |
Indian Promoters | % | 0.0 | 46.8 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 21.5 | 0.1 | 26,812.5% | |
FIIs | % | 6.6 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 53.2 | 90.6% | |
Shareholders | 54,792 | 26,422 | 207.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | BIOFIL CHEMICALS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.62% | 0.78% | 1.23% |
1-Month | -0.33% | -9.76% | -0.24% |
1-Year | -1.57% | 23.39% | 43.62% |
3-Year CAGR | 0.56% | 0.98% | 20.35% |
5-Year CAGR | 3.69% | 63.45% | 26.24% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the BIOFIL CHEMICALS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of BIOFIL CHEMICALS the stake stands at 46.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of BIOFIL CHEMICALS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 260.0 per share. This amounted to a Dividend Payout ratio of 214.7%.
BIOFIL CHEMICALS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of BIOFIL CHEMICALS.
For a sector overview, read our pharmaceuticals sector report.
Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.